Shares News

Latest data from asset manager NN Investment Partners shows that the risk premium on Japanese stocks has hit a record 8.8%. The equity risk premium is how much extra investors should expect to get back from buying shares over the risk-free rate. In other words, if you put £1,000 into the FTSE 100, how much more would you likely get back after a year versus sticking your cash in the bank, or ...

UK stocks are drifting into mid-week with the FTSE 100 index down 0.3% to 7,157 on weakness in banks, healthcare and utilities, while construction stocks, miners and telecoms help underpin recent gains. Housebuilder Barratt Developments (BDEV) releases a strong set of half year results with profits growing faster than revenues which is always a good sign. For the six months to the end of ...

At Baillie Gifford, we generally prefer our research to appear irrelevant. The further it is from being a direct debate about the merits of a company as an investment the happier we tend to be. Much of the most valuable research is deeply indirect in its investment implications and surprising in its eventual impact. The value of an investment and any income from it is not guaranteed and may go ...

Up to 80% of Indivior’s (INDV) market share for its opioid addiction treatment is at immediate risk after a US court denied its appeal to stop Dr Reddy’s Laboratories (DRL) launching a generic rival. The company is also bracing itself for an upcoming generic launch by drug manufacturer Alvogen Pine Brook. Indivior has been trying to stop DRL from launching a generic version of its ...

Shares in online grocer-turned-e-commerce technology platform Ocado (OCDO) tick up 3.4p to 996p, despite full year results revealing a materially widened annual loss. Bulls are seizing on chief executive officer (CEO) Tim Steiner’s insistence that Ocado’s growth story is ‘only just beginning’. Conspicuous by its absence however is any mention of the rumoured food delivery tie-up with ...

Drug developer Indivior (INDV) has warned that it faces the loss of up to 80% of its market share ‘in a matter of months’ after losing a court ruling in the US over its Anti-opioid treatment Suboxone. Suboxone is used as a substitute to get drug addicts off harmful opiods, such as heroin. The company has been fighting a bitter battle for months against generic competitor drugs being made ...

Ryanair (RYA) chief executive officer Michael O’Leary will be sticking around until at least July 2024 under a new group structure that will hopefully help the embattled carrier navigate difficult times. Airlines have been struggling with trade disputes, rising fuel prices and overcapacity, forcing companies to slash prices to get more bums on seats. Over the next year, Ryanair plans to ...

Shares in professional services firm RPS (RPS) jump 8% to 150p after it confirms that full year earnings for 2018 will be in line with lowered market expectations. Last October the company warned that ‘necessary investment in the business’ meant pre-tax profits would be below expectations, which at the time were in the region of £55m. The shares tumbled 27% from 207 to 150p on the day ...

As you begin to explore the world of investing you may find people talking about the 'fundamentals' behind an individual stock or even the wider market. But what exactly are they talking about and why are these fundamentals important? Fundamental analysis is a method of evaluating an asset that includes an attempt to measure its intrinsic value by examining anything that could affect its ...

Markets are steady at the start of the new week with sterling rising against the euro and US dollar. The FTSE 100 advances 19 points higher to 7,039.2 led by Royal Dutch Shell (RDSB) and BP (BP.), which are lifted by a stronger oil price. Belfast-based IT business Kainos (KNOS) sparks up 7.8% to 458p on the very welcome news results for the year to March will be ahead of market ...